These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 73969)
1. Hypolipidaemic agents: What are they good for? Manninen V; Mälkönen M; Tuomilehto J Lancet; 1977 Dec; 2(8051):1281-2. PubMed ID: 73969 [No Abstract] [Full Text] [Related]
2. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
3. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR; Yeshurun D; Jackson RL; Gotto AM Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
5. [Familial hyperlipoproteinemia type III]. Patsch JR; Patsch W; Sailer S; Braunsteiner H Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
6. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451 [No Abstract] [Full Text] [Related]
7. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
9. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
10. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial. Carlson LA; Olsson AG Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108 [No Abstract] [Full Text] [Related]
12. A physician's guide to hyperlipidemia. Fredrickson DS Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
13. Type IV hyperlipoproteinaemia. Kwiterovich PO; Margolis S Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117 [No Abstract] [Full Text] [Related]
14. Hyperlipoproteinemia. Some basic concepts on diagnosis and management. Levy RI JAMA; 1973 Nov; 226(6):648-9. PubMed ID: 4356846 [No Abstract] [Full Text] [Related]
15. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia. Miettinen TA; Penttilä IM; Lampainen E Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290 [No Abstract] [Full Text] [Related]
17. Secholex, Clofibrate and taurine in hyperlipidaemia. Howard AN; Evans RJ Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405 [No Abstract] [Full Text] [Related]
18. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV]. Jantke J; Schwartzkopff W; Zschiedrich M Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057 [No Abstract] [Full Text] [Related]
19. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. Carlson LA; Olsson G; Ballantyne D Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526 [TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil treatment: a comparison with clofibrate. Howard AN; Ghosh P Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]